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cases, our data suggest that hypomorphic mutations (missense, splice sites) are
less frequently associated to a heart defect than nonsense and frameshift muta-
tions.
Conclusions: Although being a minor criteria because of lack of speci-
ficity, CVM proved to be very frequent in CHD7 mutated CHARGE patients.
The neural crest cells origin hypothesis of the CVM cannot account for all
observed defects. Cardiac progenitor cells of the second heart field might be
implicated in embryological mechanisms leading to CVM in CHARGE syn-
drome.
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Background: Therapeutic options at time of worsening remain unclear in
children who do worse but remain in functional class III while being on com-
bined oral therapy with endothelin receptor antagonists and PDE-5 inhibitors.
Objective: To evaluate the use of a subcutaneous prostanoid as an ad-on
therapy in pediatric PAH.
Patients and methods: Five children with PAH (median age 4 years,
range 1.5–9 y) received subcutaneous treprostinil at time of worsening PAH.
Two had idiopathic PAH, one being familial. Three patients had PAH asso-
ciated with but not caused by congenital heart defect. All had severe PAH
and were non responsive to inhaled nitric oxide. They were all on combined
oral therapy with bosentan and sildenafil. Indication to add treprostinil was
clinical deterioration with right ventricular failure in 4 patients and switch
from IV epoprostenol in one. Treprostinil was initiated at a fixed dose of
1.25 ng/kg/min and then daily increased by 1.25 ng/kg/min to reach an
average dose of 20 ng/kg/min.
Results: Local tolerance was good with tailored management of site injec-
tion. No serious adverse events was noted during the median 6 months follow-
up. All patients were clinically improved with significant increase in 6MWT
distance in the 3 oldest children and change from WHO functional class III to
class II. Echocardiography showed an improved right ventricular function,
increased pulmonary flow with increased acceleration time.
Conclusion: Subcutaneous treprostinil can be a valuable alternative in
pediatric PAH patients already receiving combined oral therapy. It may help
to avoid complications of central lines and to improve quality of life.
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Background: 3D echocardiography is a validated method to evaluate left
ventricular (LV) volumes and function. Because of its peculiar morphology,
the right ventricle (RV) volumes can not be calculated with 3D softwares used
for LV quantification. Recently, new 3D software adapted for RV morphology
was introduced.
Aim: To evaluate the feasibility of 3D RV analysis in a pediatric popula-
tion and to compare RV 3D data with LV 3D measurements.
Methods: Fifty-one pediatric patients (median age 10 years) with normal
cardiac anatomy and function were included. 3D transthoracic echocardio-
graphy was performed with the X4-2 or X7-2 matrix probe (ie33, Philips Med-
ical Systems, Andover, MA). Three LV and RV full volume sweeps were
acquired from apical views. The volumes were analysed with the LV and the
dedicated RV analysis softwares (TomTec Imaging Systems, Munich, Ger-
many).
Results: Measurements feasibility was 100% for LV and 95% for RV. The
RV had higher volumes but smaller ejection fraction compared to LV (RV
end-diastolic volume 59 ml, LV end-diastolic volume 46 ml; RV end-systolic
volume 29 ml, LV end-systolic volume 17 ml; RV ejection fraction 53%, LV
ejection fraction 66%).The stroke volumes of the two ventricles were highly
related with a mean difference of 1+/-2 ml (r= 0,95). The intra- and interob-
server variabilities ranged from RV 3D volumes (0.4%-2%, and 0.2%-4%).
Conclusion: 3D echocardiography using dedicated software is a feasible
and adequate method for RV volume quantification in a normal pediatric pop-
ulation. Further studies are needed to validate the accuracy of the method to
calculate enlarged RV volumes in patients with congenital heart diseases. 
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Background: Despite successful surgical correction, morbidity of patients
with coarctation of the aorta(CoAo) is high. The increased large arteries stiff-
ness may be related to their impaired prognosis.
Purpose: The aim of the study is to asses the relationship between aortic
stiffness parameters (2D echo), aortic wall velocities (tissue Doppler imaging,
TDI) and carotid stiffness parameters (e-tracking) in pts. with repaired CoAo.
Methods: Study group consisted of 23 pts. with repaired CoAo (mean age
28,6 ± 9,9 yrs) and 20 matched healthy subjects.
Aortic elasticity was assessed using M-mode evaluation of aortic diame-
ters, then calculating accepted indexes: aortic strain (Ao Strain), distensibility
(Ao Dis), stiffness index (Ao SI). 
Systolic maximum expansion velocity (SW) of aortic wall was assesed
using TDI.E-tracking determined parameters were: pulse wave velocity
(PWV), stiffness index (β), elastic modulus (Ep), arterial compliance (AC).
Results: When correlating (table) the parameters derived from the 3
methods, statistical significant association (*) was obtained for Ao M-mode
3D reconstruction of the right ventricle
© Elsevier Masson SAS. All rights reserved.
 
106 Archives of Cardiovascular Diseases Supplements (2010) 2, 100-106
derived stiffness parameters and SW. Only PWV correlated with Ao Dis and
Ao Strain, while PWV and β correlated with SW. 
Conclusions: Precoarctational bed arteries stiffness parameters assessed
by different techniques showed partly concordant results. While M-mode
derived parameters of aortic elasticity are time-consuming, they could be
replaced in daily practice by aortic wall TDI evaluation. Carotid stiffness
indexes measured by e-tracking are complementary to aortic stiffness param-
eters.
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Purpose: Percutaneous closure of patent ductus arteriosus (PDA) using the
Amplatzer duct occluder (ADO) is an effective and a true alternative to sur-
gical closure. However, closure of PDA in infants with a low weight remains
challenging for the interventionist.
Methods: From April 1999 to February 2009, 203 patients underwent percu-
taneous PDA closure. We focus here on the 17 infants weighing ≤ 6 kg and in
whom duct was closed using the ADO. All patients were symptomatic: failure
to thrive, dyspnoea, and frequent respiratory infections. There were 15 females
and 2 males. At implantation, the mean age was 5.1 ± 4 months, and the mean
weight was 4.6 ± 0.9 (range 2.8 to 6 kg). The procedure was realized under local
anaesthesia (n = 14) and general anaesthesia (n = 3). In 5 of the 17 pts, implan-
tation was performed from a sole venous femoral access without arterial punc-
ture and device release was controlled by transthoracic echocardiography. Size
of the duct was 3.6 ± 1.3 mm (range 1.7 to 6 mm) and systolic pulmonary artery
pressure was 54 ± 19 mm Hg (range 26 to 96 mm Hg). Implantation succeeded
in all but one without any adverse event. Closure was performed by six 5/4 mm
ADO, five 6/4 mm ADO, five 8/6 mm ADO, and one 10/8 mm ADO. One
patient with failed procedure underwent subsequently surgical closure of the
duct. During follow-up (0 to 58 months), Doppler echocardiography showed
decrease in ductal shunting: complete occlusion was noticed in 5 pts at day one,
10 pts at one month, 14 pts at 3 months, and 16 pts at one year after implanta-
tion. No patient but one had persistent pulmonary hypertension and only one had
a moderate stenosis on the left pulmonary artery due to device protrusion. One
patient died 15 months after implantation from a non related device cause.
Conclusions: In skilled hands, percutaneous closure of large PDA in symp-
tomatic infants weighing ≤ 6 kg is safe and effective. Such procedure can solve
clinical problems and offer a real alternative to the classic surgical correction.
 Ao Dis Ao Strain Ao SI SW
PWV -,343(*) -,349(*) 0,01 -,388(*)
AI -0,12 -0,16 0,08 -0,2
Beta -0,22 -0,22 0,09 -,373(*)
Ep -0,26 -0,26 -0,03 -0,29
AC 0,17 0,13 0,08 -0,12
SW ,554(**) ,578(**) -,494(**)  
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